Dl-Tryptophan

Dl-Tryptophan

SCHEMBL26977255

CC(O)C(N)C(=O)O.NC(=O)CCC(N)C(=O)O.NC(Cc1c[nH]c2ccccc12)C(=O)O.NC(Cc1ccc(O)cc1)C(=O)O

nearest known ligand 0.57

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KMT2A Q03164 3/20 0.57
▸ KDM4E B2RXH2 3/20 0.57
▸ MAPT P10636 3/20 0.57
▸ LMNA P02545 2/20 0.57
▸ TSHR P16473 2/20 0.57
▸ BLM P54132 2/20 0.57
▸ PMP22 Q01453 2/20 0.57
▸ MEN1 O00255 2/20 0.57
▸ MPO P05164 1/20 0.57
▸ HIF1A Q16665 1/20 0.57
▸ ALDH1A1 P00352 1/20 0.52
▸ CYP3A4 P08684 1/20 0.52
▸ HTR1A P08908 1/20 0.52
▸ ADORA3 P0DMS8 1/20 0.52
▸ ALOX15 P16050 1/20 0.52
▸ NFKB1 P19838 1/20 0.52
▸ HTR2A P28223 1/20 0.52
▸ HTR2C P28335 1/20 0.52
▸ SLC6A4 P31645 1/20 0.52
▸ HTR7 P34969 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Tryptophan SCHEMBL5605980 0.93 KDM4E (0.67) KMT2AKDM4EMAPTLMNATSHR
Tryptophan SCHEMBL4261643 0.93 KDM4E (0.67) KMT2AKDM4EMAPTLMNATSHR
Tryptophan SCHEMBL5605972 0.93 KDM4E (0.67) KMT2AKDM4EMAPTLMNATSHR
Dl-Tryptophan SCHEMBL17889024 0.93 KDM4E (0.67) KMT2AKDM4EMAPTLMNATSHR
Dl-Tryptophan SCHEMBL26977489 0.93 KMT2A (0.67) KMT2AKDM4EMAPTLMNATSHR
Tryptophan SCHEMBL1833538 0.90 KDM4E (0.63) KMT2AKDM4EMAPTLMNATSHR
Tryptophan SCHEMBL1833542 0.90 KDM4E (0.63) KMT2AKDM4EMAPTLMNATSHR
Dl-Tryptophan SCHEMBL28813398 0.89 KDM4E (0.61) KMT2AKDM4EMAPTLMNATSHR
Tryptophan SCHEMBL9397492 0.89 KDM4E (0.61) KMT2AKDM4EMAPTLMNATSHR
Dl-Tryptophan SCHEMBL27901971 0.89 KDM4E (0.61) KMT2AKDM4EMAPTLMNATSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240050513-A1 COMPOSITION FOR PREVENTING, AMELIORATING, OR TREATING DISEASE CAUSED BY PROTEIN NITRATION COMPRISING PEPTIDE WITH TERMINAL TYROSINE AS EFFECTIVE COMPONENT INDUSTRY-ACADEMIC COOPERATION FOUNDATION GYEONGSANG NATIONAL UNIVERSITY (KR) 2024-02-15 — — US disclosed
EP-4298924-A1 COMPOSITION, FOR PREVENTING, RELIEVING, OR TREATING DISEASE CAUSED BY NITRATION OF PROTEIN, CONTAINING PEPTIDE HAVING TYROSINE LOCATED AT TERMINAL AS ACTIVE INGREDIENT Industry-Academic Cooperation Foundation Gyeongsang National University (KR) 2024-01-03 — — EP disclosed
CN-116916765-A Composition for preventing, improving or treating diseases caused by protein nitrification comprising peptide having tyrosine at its end as active ingredient 庆尚国立大学校 产学协力团 2023-10-20 — — CN disclosed
Send feedback